000			03715nam a2200433 i 4500
999			_c362931 _d362931 _x1
001			362931
003			ES-MaUEC
005			20230102121635.0
006			a||||fo|||| 00| 0
007			cr nn 008mamaa
008			210625s2021 gw a s |||| 0|eng d
020			_a9783030741037
024	7		_a10.1007/978-3-030-74103-7 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aRE727 _b2021 EB
245	0	0	_aControversies in Neuro-Ophthalmic Management . _bAn Evidence and Case-Based Appraisal _cedited by Amanda D. Henderson, Andrew R. Carey
250			_aFirst edition 2021
264		1	_aCham _bSpringer International Publishing _c2021
264		4	_c2021
300			_a1 recurso en línea (VIII, 288 páginas) _b41 ilustraciones, 17 ilustraciones a color
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_aArchivo de texto _bPDF
505	0		_aI. Introduction -- 1. Purpose of this Book -- II. Optic neuropathies -- 2. Non-arteritic anterior ischemic optic neuropathy -- 3. Radiation optic neuropathy -- 4. Optic neuritis -- 5.Traumatic optic neuropathy -- 6. Papilledema -- 7. Leukemic infiltration of the optic nerve -- 8. Infectious optic neuropathy -- 9. Hereditary optic neuropathy -- 10. Compressive optic neuropathy -- III. Ocular motility disorders -- 11. Transient diplopia -- 12. Third nerve palsy -- 13. Sixth nerve palsy -- 14. Fourth nerve palsy -- 15. Multiple cranial neuropathies -- 16. Nystagmus -- IV. Transient visual symptoms -- 17. Transient monocular vision loss -- 18. Transient binocular vision loss -- 19. Visual aura -- V. Pain -- 20. Migraine -- 21. Trigeminal autonomic cephalgia headaches -- 22. Post-concussive syndrome -- VI. Systemic disease -- 23. Giant cell arteritis -- 24. Myasthenia gravis.-25. ophthalmopathy -- 26. Sarcoidosis.
520			_aThis book functions as a resource for providers who treat patients with neuro-ophthalmic conditions. Using an evidence-based approach to controversial management decisions, the material is presented in a digestible, case-based format. Divided into six sections, the book begins with an introduction to its framework, format, and purpose. Following this, sections two, three, and four discuss various optic neuropathies, ocular motility disorders, and transient visual symptoms. The concluding sections then address neuro-ophthalmic manifestations of pain, including migraine and post-concussive syndrome, and systemic diseases, such as giant cell arteritis. Each chapter focuses on cases that are historically complex, or which have undergone a recent shift in traditional management due to new scientific discoveries or newly available therapies. Controversies in Neuro-Ophthalmic Management presents essential, thorough information on management options and the data for their use to provide the best care for patients.
988			_aSpringer_Medicine_2021
650		7	_2embne _9666201 _aNervios craneales _xEnfermedades
700	1		_aHenderson, Amanda D. _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aCarey, Andrew R. _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
776	0	8	_iPrinted edition: _z9783030741020
776	0	8	_iPrinted edition: _z9783030741044
776	0	8	_iPrinted edition: _z9783030741051
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-74103-7 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b02/2022 _dz _ek _zSI